NCT05861791

Brief Summary

Patients who undergoing total knee arthroplasty under spinal analgesia will be recruited and randomly assigned to the following two groups according to the regimen of PCA: (A) opioid group who receive only fentanyl citrate 1200mcg for continuous infusion drug, (B) non-opioid group who receive ketorolac tromethamine 150mg with nefopam hydrochloride 100mg for continuous infusion drug. All the patients will receive additional fentanyl citrate as bolus injection drug if they need more analgesics postoperatively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 7, 2023

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

February 8, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 17, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 12, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2024

Completed
Last Updated

July 15, 2024

Status Verified

July 1, 2024

Enrollment Period

1.4 years

First QC Date

February 8, 2023

Last Update Submit

July 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • postoperative pain score

    evaluated by visual analogue scale

    24 hours after the surgery

Study Arms (2)

opioid group

EXPERIMENTAL

IV-PCA consisted of fentanyl

Drug: Fentanyl

non-opioid group

ACTIVE COMPARATOR

IV-PCA consisted of ketorolac and nefopam

Drug: ketorolac tromethamine with nefopam hydrochloride

Interventions

opioid group receives only fentanyl citrate 1200mcg for continuous infusion drug

Also known as: opioid group
opioid group

non-opioid group receives ketorolac tromethamine 150mg with nefopam hydrochloride 100mg for continuous infusion drug

non-opioid group

Eligibility Criteria

Age60 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA physical status I-II
  • undergoing elective total knee arthroplasty under spinal anesthesia

You may not qualify if:

  • history of stomack ulceration
  • increased ICP
  • bronchial asthma
  • allergy on aspirin, NSAIDs, Nefopam
  • drug user of antiplatelet or anticoagulant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ChungAng University Gwangmyeong Hospital

Gyeonggi-do, Gwangmyeon-si, 14353, South Korea

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

FentanylKetorolac TromethamineNefopam

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsIndomethacinIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingOxazocinesAzocines

Study Officials

  • Se-Hee Min

    ChungAng University Gwangmyeon Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

February 8, 2023

First Posted

May 17, 2023

Study Start

February 7, 2023

Primary Completion

July 12, 2024

Study Completion

July 12, 2024

Last Updated

July 15, 2024

Record last verified: 2024-07

Locations